Indication
Transfusion-dependent Anemia
5 clinical trials
5 products
1 drug
Product
DeferasiroxClinical trial
A Randomized, Open-label, Multicenter, Two Arm, Phase II Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients With Iron OverloadStatus: Completed, Estimated PCD: 2018-05-31
Clinical trial
Liberal Transfusion Strategy to Prevent Mortality and Anaemia-associated, Ischaemic Events in Elderly Non-cardiac Surgical PatientsStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Red blood cell transfusionClinical trial
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to Myelodysplastic Syndromes With del5q, Refractory/Resistant/Intolerant to Prior Treatments, Who Require Red Blood Cell TransfusionsStatus: Recruiting, Estimated PCD: 2024-04-03
Product
LuspaterceptClinical trial
Tranexamic Acid for Reduction of Intra- and Postoperative Transfusion Requirements in Elective Abdominal Surgery: Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-11-30
Product
Tranexamic AcidDrug
VarlilumabClinical trial
Prediction of Transfusion-Associated ComplicationsStatus: Completed, Estimated PCD: 2022-07-31